The catering manager for a local secondary school explained that making the decision to receive cold cap treatment was one of ...

Women had a lower probability of receiving any disease-modifying treatment (DMT) and were even less likely to get ...

IN the serene, sunbathed town of Mombo, nestled in Tanzania’s Tanga Region, along the Tanga -Arusha Highway, a quiet ...

Liza Colón-Zayas may have just won her first Emmy for Outstanding Supporting Actress in a Comedy Series for her role as Tina ...

Among 282 patients with pediatric-onset MS, 39% started high-efficacy therapy early (at ages 12-17), and 61% started late ...

The Bruton's tyrosine kinase inhibitor tolebrutinib is reportedly the first agent to show benefit in patients with nonrelapsing secondary progressive MS.

Alizabeth Rhodes was taken to the ER in her home state with 'non-specific' symptoms at the age of 16 years - which may have ...

Johnston (16) died of meningitis after she was left for more than 13 hours at UHL without ‘vital’ antibiotic treatment, ...

Sangeetha Venugopal, MD, MS, discussed the evolving landscape of acute myeloid leukemia treatment as well as unmet needs ...

Vitamin D is linked to a 34% reduction in the relative risk for disease activity in patients with clinically isolated ...

Researchers have identified biomarkers that can predict disease progression in multiple sclerosis, which could lead to the ...

Data from the HERCULES trial presented at the ECTRIMS conference in Copenhagen, Denmark, today showed that tolebrutinib was ...